Guwahati News Desk: India’s first indigenous COVID-19 vaccine COVAXIN has been cleared for phase 3 clinical trails.
The COVAXIN is developed by Hyderabad based biotech company named Bharat Biotech.
The vaccine is developed in collaboration with the Indian Council of Medical Research (IMCR).
The biggest and the busiest hub of Northeast India 24x7 News Media House.
Copyright for all content remains solely with Hello Guwahati. The news stories or content including images and videos can be re-published and re-telecast by other parties only with prior approval of Hello Guwahati with the condition that other parties must include the link to the original post by Hello Guwahati in their posts.
